Biotage AB (publ)
BITGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13 | $9 | $12 | $17 |
| - Cash | $0 | $1 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $13 | $9 | $11 | $17 |
| Revenue | $2 | $2 | $2 | $1 |
| % Growth | 10.4% | 18.9% | 27.1% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 62.7% | 61.7% | 60.5% | 61.3% |
| EBITDA | $1 | $0 | $0 | $0 |
| % Margin | 25.8% | 25% | 29% | 28.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 13.8% | 13.2% | 17.1% | 16.6% |
| EPS Diluted | 3.55 | 0.33 | 0.39 | 0.34 |
| % Growth | 975.8% | -15.4% | 14.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |